You are here

Article Text

Article menu
Download PDFPDF
Commentary
COVID-19 meets neurointervention on the pages of JNIS
  1. James M Milburn1,
  2. Robert W Regenhardt2,
  3. Jens Fiehler3,
  4. Kyle M Fargen4,
  5. Joshua A Hirsch2
  1. 1 Department of Radiology, Ochsner Health System, New Orleans, Louisiana, USA
  2. 2 NeuroEndovascular Program, Massachusetts General Hospital, Boston, Massachusetts, USA
  3. 3 Department of Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Hamburg, Germany
  4. 4 Department of Neurological Surgery and Radiology, Wake Forest University, Winston-Salem, North Carolina, USA
  1. Correspondence to Dr Joshua A Hirsch, NeuroEndovascular Program, Massachusetts General Hospital, Boston, Massachusetts, USA; hirsch{at}snisonline.org

https://doi.org/10.1136/neurintsurg-2021-017722

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    As 2019 came to a close, a novel B-coronavirus, labeled by the World Health Organization as COVID-19, was noted to be spreading in China.1 The COVID-19 virus is an enveloped single-strand, positive-sense RNA, which means that the virus can use its RNA as the template from which to create proteins needed for propagation and, ultimately, spread. The name coronavirus refers to the characteristic crown-like appearance of these viruses that is seen on electron microscopy. By spring 2020, COVID-19 was spreading rapidly throughout the United States and Europe, and neurointerventionalists soon found themselves on the frontline.2 The Journal of NeuroInterventional Surgery (JNIS) rapidly became the home for emerging research aimed at promoting the safe management of patients with COVID-19 and concomitant cerebrovascular disease and in understanding the consequences of the pandemic on patients, providers, and stroke care.

    COVID-19 was initially described largely in terms of its protean pulmonary manifestations, but it soon became apparent that thrombogenic tendencies elevated the risk of stroke.3 Understanding how to approach potentially infectious patients became a major focus of a diverse group of articles being submitted to JNIS.4 New York City …

    View Full Text

    Footnotes

    • Twitter @docroc99, @rwregen, @Fie0815, @JoshuaAHirsch

    • Contributors All authors have participated in the drafting and editing of this commentary. Each has read and approved the final version.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests JMM, JF, KMF, and JAH are members of the Journal of NeuroInterventional Surgery editorial board.

    • Provenance and peer review Not commissioned; internally peer reviewed.